NDC 60687-523

Posaconazole

Posaconazole

Posaconazole is a Oral Tablet, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by American Health Packaging. The primary component is Posaconazole.

Product ID60687-523_a7466172-fba8-6aed-e053-2a95a90a74cb
NDC60687-523
Product TypeHuman Prescription Drug
Proprietary NamePosaconazole
Generic NamePosaconazole
Dosage FormTablet, Delayed Release
Route of AdministrationORAL
Marketing Start Date2020-06-01
Marketing CategoryANDA / ANDA
Application NumberANDA212411
Labeler NameAmerican Health Packaging
Substance NamePOSACONAZOLE
Active Ingredient Strength100 mg/1
Pharm ClassesAzole Antifungal [EPC],Azoles [CS]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 60687-523-21

30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-523-21) > 1 TABLET, DELAYED RELEASE in 1 BLISTER PACK (60687-523-11)
Marketing Start Date2020-06-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 60687-523-11 [60687052311]

Posaconazole TABLET, DELAYED RELEASE
Marketing CategoryANDA
Application NumberANDA212411
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-06-01

NDC 60687-523-21 [60687052321]

Posaconazole TABLET, DELAYED RELEASE
Marketing CategoryANDA
Application NumberANDA212411
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-06-01

Drug Details

NDC Crossover Matching brand name "Posaconazole" or generic name "Posaconazole"

NDCBrand NameGeneric Name
0254-2045POSACONAZOLEposaconazole
0406-7711POSACONAZOLEposaconazole
0527-2133POSACONAZOLEPosaconazole
60687-523PosaconazolePosaconazole
70748-258POSACONAZOLEPOSACONAZOLE
0085-1328NOXAFILposaconazole
0085-2224NOXAFILposaconazole
0085-4324NOXAFILposaconazole
0085-4331NOXAFILposaconazole
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.